His episode runs hormones, peptides and other longevity fads through a three verdict test to separate solid science from hype or risk.
Recap by typeshit. Post by @rod.rohrich on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Lembke, known for her work on addiction, discusses what FDA-approved GLP-1 weight loss drugs could do beyond weight. Details are on Stanford Medicine.
:fill(white)/media.spokesman.com/graphics/2020/08/sr_placeholder.png)
The no-cost list covers more than 250 medications across most Walmart plans. Workers will need a new prior authorization to get the GLP-1s free.
Loading…